We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
-3.92%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
-$14.4M
Cap. Flow
+$35M
Cap. Flow %
2.96%
Top 10 Hldgs %
62.21%
Holding
83
New
12
Increased
32
Reduced
19
Closed
14

Top Buys

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$27.9M
2
HQY icon
HealthEquity
HQY
+$22.9M
3
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$15.2M
4
GSK icon
GSK
GSK
+$13.4M
5
TSVT
2seventy bio
TSVT
+$9.53M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$29M
2
CTLT
CATALENT, INC.
CTLT
+$15.5M
3
ICLR icon
Icon
ICLR
+$12.8M
4
ABCM
Abcam PLC
ABCM
+$12.2M
5
AMRX icon
Amneal Pharmaceuticals
AMRX
+$9.77M

Sector Composition

Rank Sector Weight
1 Healthcare 76.1%
2 Miscellaneous 23.9%
3 Communication Services 0%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELV icon
26
Elevance Health
ELV
$85.5B
$9.45M 0.8%
21,694
+19,379
+837% +$8.79M
LQDA icon
27
Liquidia Corp
LQDA
$6.06B
$8.85M 0.75%
1,395,454
+470,010
+51% +$3.39M
HUM icon
28
Humana
HUM
$46.3B
$8.82M 0.75%
18,121
+6,194
+52% +$2.91M
IBB icon
29
PUT
iShares Biotechnology ETF
IBB
$10.5B
$8.6M 0.73%
+70,300
New +$8.94M
TLT icon
30
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$46.8B
$8.31M 0.7%
+93,700
New +$9.01M
AMRN
31
Amarin Corp
AMRN
$295M
$7.76M 0.66%
421,594
-103,511
-20% -$2.24M
VRDN icon
32
Viridian Therapeutics
VRDN
$2.61B
$6.8M 0.58%
+443,270
New +$8.46M
HYG icon
33
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.6B
$6.63M 0.56%
+90,000
New +$6.72M
WAT icon
34
Waters Corp
WAT
$40.7B
$6.34M 0.54%
23,124
+12,196
+112% +$3.37M
NAMS icon
35
NewAmsterdam Pharma
NAMS
$3.1B
$6.11M 0.52%
660,618
-31,751
-5% -$344K
XBI icon
36
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$5.84M 0.49%
80,000
-10,000
-11% -$799K
TSVT
37
DELISTED
2seventy bio
TSVT
$5.7M 0.48%
+1,453,378
New +$9.53M
MCRB icon
38
Seres Therapeutics
MCRB
$51.3M
$5.6M 0.47%
117,628
-36,210
-24% -$2.76M
TSHA icon
39
Taysha Gene Therapies
TSHA
$1.88B
$5.39M 0.46%
+1,705,774
New +$3.19M
IFRX icon
40
InflaRx
IFRX
$329M
$5.18M 0.44%
1,737,544
-177,569
-9% -$676K
ICLR icon
41
Icon
ICLR
$13.1B
$5.17M 0.44%
20,998
-50,728
-71% -$12.8M
PTGX icon
42
Protagonist Therapeutics
PTGX
$9.34B
$4.78M 0.4%
286,748
+172,089
+150% +$3.34M
A icon
43
Agilent Technologies
A
$43.4B
$4.68M 0.4%
41,825
+13,365
+47% +$1.6M
APLS
44
DELISTED
Apellis Pharmaceuticals
APLS
$4.67M 0.39%
122,643
+66,194
+117% +$2.91M
IQV icon
45
IQVIA
IQV
$43.1B
$4.53M 0.38%
23,041
+4,293
+23% +$932K
MRVI icon
46
Maravai LifeSciences
MRVI
$1.14B
$4.52M 0.38%
+452,323
New +$4.97M
PBYI icon
47
Puma Biotechnology
PBYI
$468M
$4.42M 0.37%
1,681,149
+22,954
+1% +$78.2K
AMN icon
48
PUT
AMN Healthcare
AMN
$1.34B
$4.26M 0.36%
50,000
-45,000
-47% -$4.27M
PNTG icon
49
Pennant Group
PNTG
$1.3B
$4.07M 0.34%
365,899
-65,723
-15% -$761K
MOH icon
50
Molina Healthcare
MOH
$10.4B
$4.01M 0.34%
12,234
-9,020
-42% -$2.84M
1
2
3 4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Eversept Partners held 83 positions worth $1.18B, down 1.2% from $1.2B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Eversept Partners's Q3 2023 filing shows 12 new, 32 increased, 19 reduced and 14 closed positions. Its largest new stake was HealthEquity: 338,516 shares worth $24.7M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $29M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 78% a quarter earlier, followed by Miscellaneous and Communication Services.

  • Eversept Partners's largest Q3 2023 buy was HealthEquity: 338,516 shares worth $24.7M.
  • Eversept Partners added most to Inspire Medical Systems in Q3 2023, an estimated $27.9M increase.
  • Eversept Partners's biggest Q3 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $29M.
  • Eversept Partners fully exited CATALENT, INC. in Q3 2023, selling an estimated $15.5M.
  • Eversept Partners's ten largest holdings make up 62% of its $1.18B portfolio in Q3 2023.
  • Eversept Partners opened 12 new positions and closed 14 in Q3 2023.
  • Eversept Partners's portfolio value fell 1.2% quarter-over-quarter to $1.18B.

Based on Eversept Partners's 13F filing for Q3 2023, filed 14 Nov 2023.